Opioid Prescribing in Canada following the Legalization of Cannabis: A Clinical and Economic Time-Series Analysis
ConclusionsOur findings support the hypothesis that easier access to cannabis for pain may reduce opioid use for both public and private drug plans.
Source: Applied Health Economics and Health Policy - Category: Health Management Source Type: research
More News: Canada Health | Economics | Fentanyl | Gabapentin | Health Management | Hydrocodone | Legislation | Lyrica | Morphine | Neurontin | Oxycodone | OxyContin | Pain | Pain Management | Study | Tramadol